Cutler Group LP Moon Lake Immunotherapeutics Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

Apr 19, 2024
BUY
$43.78 - $63.86 $61,292 - $89,404
1,400 Added 45.16%
4,500 $43,000
Q4 2023

Jan 18, 2024
SELL
$36.35 - $63.02 $258,085 - $447,442
-7,100 Reduced 69.61%
3,100 $31,000
Q3 2023

Nov 07, 2023
BUY
$48.35 - $61.26 $493,170 - $624,852
10,200 New
10,200 $30,000

Others Institutions Holding MLTX

# of Institutions
124
Shares Held
58.2M
Call Options Held
52.2K
Put Options Held
38K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.92B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email